Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo de estudio
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Clin Gastroenterol Hepatol ; 18(11): 2628-2630, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-31546060

RESUMEN

Tissue transglutaminse-2 (TG2)-based immunoassays are the cornerstone of diagnosis in celiac disease (CeD), with a reported pooled sensitivity as high as 98%.1 However, a few small, single-center studies have questioned their sensitivity in clinical practice.2-5 Moreover, commercial kits use variable TG2 antigens,6 with cutoffs determined by using small, poorly defined populations. Variation in diagnostic performance of anti-TG2 assays in different racial and geographic populations has not yet been studied. We compared the interassay and intra-assay variations in diagnostic performance of 4 immunoglobulin (Ig)A-anti-TG2 assays in Canadian and Indian populations.


Asunto(s)
Enfermedad Celíaca , Transglutaminasas , Autoanticuerpos , Canadá , Enfermedad Celíaca/diagnóstico , Humanos , Inmunoensayo , Inmunoglobulina A
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA